Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Masilamani

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Biotechnology|October 23, 2013
Assessment of reference genes for real-time quantitative PCR gene expression normalization during C2C12 and H9c2 skeletal muscle differentiationTwinkle J Masilamani, Julie J Loiselle, Leslie C Sutherland
International Journal of Obesity (2005)|May 19, 2010
Cord lining progenitor cells: potential in vitro adipogenesis modelH H Cheong, J Masilamani, T T Phan, et al.
Chinese Medical Journal|August 14, 2012
Downregulating activated epidermal growth factor receptor has no effect on RBM5 expressionTwinkle J Masilamani, Nina D Rintala-Maki, Ke Wang, et al.
The British Journal of Dermatology|February 5, 2010
Comparative proteomic analysis between normal skin and keloid scarC T Ong, Y T Khoo, A Mukhopadhyay, et al.
Gene|January 20, 2016
Co- and post-transcriptional regulation of Rbm5 and Rbm10 in mouse cells as evidenced by tissue-specific, developmental and disease-associated variation of splice variant and protein expression levelsBartholomew Ozuemba, Twinkle J Masilamani, Julie J Loiselle, et al.
Scientific Reports|May 28, 2020
The RNA disruption assay is superior to conventional drug sensitivity assays in detecting cytotoxic drugsJonathan P J Mapletoft, Renée J St-Onge, Baoqing Guo, et al.
Journal of Cellular and Molecular Medicine|May 13, 2009
Hepatoma-derived growth factor and its role in keloid pathogenesisB N S Ooi, A Mukhopadhyay, J Masilamani, et al.
The British Journal of Dermatology|September 18, 2010
The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?A Mukhopadhyay, D V Do, C T Ong, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Biotechnology|October 23, 2013
Assessment of reference genes for real-time quantitative PCR gene expression normalization during C2C12 and H9c2 skeletal muscle differentiationTwinkle J Masilamani, Julie J Loiselle, Leslie C Sutherland
International Journal of Obesity (2005)|May 19, 2010
Cord lining progenitor cells: potential in vitro adipogenesis modelH H Cheong, J Masilamani, T T Phan, et al.
Chinese Medical Journal|August 14, 2012
Downregulating activated epidermal growth factor receptor has no effect on RBM5 expressionTwinkle J Masilamani, Nina D Rintala-Maki, Ke Wang, et al.
The British Journal of Dermatology|February 5, 2010
Comparative proteomic analysis between normal skin and keloid scarC T Ong, Y T Khoo, A Mukhopadhyay, et al.
Gene|January 20, 2016
Co- and post-transcriptional regulation of Rbm5 and Rbm10 in mouse cells as evidenced by tissue-specific, developmental and disease-associated variation of splice variant and protein expression levelsBartholomew Ozuemba, Twinkle J Masilamani, Julie J Loiselle, et al.
Scientific Reports|May 28, 2020
The RNA disruption assay is superior to conventional drug sensitivity assays in detecting cytotoxic drugsJonathan P J Mapletoft, Renée J St-Onge, Baoqing Guo, et al.
Journal of Cellular and Molecular Medicine|May 13, 2009
Hepatoma-derived growth factor and its role in keloid pathogenesisB N S Ooi, A Mukhopadhyay, J Masilamani, et al.
The British Journal of Dermatology|September 18, 2010
The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?A Mukhopadhyay, D V Do, C T Ong, et al.
Pageof 1